logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
17/09/2025
After Nestl Chairman Paul Bulcke announced his early departure, pre-market indicators show that the company's stock price is expected to rise by 0.38%.
Latest
1 m ago
Scale AI opens platform to US Department of Defense with $100 million contract.
2 m ago
ASEAN leaders: The East Expo will promote inclusive and sustainable growth between ASEAN and China.
3 m ago
Rongchang Biotech: Currently, the overseas clinical trials of RC48 are progressing as planned.
3 m ago
Rongchang Bio (688331.SH) stated at the performance briefing that the company has reached a global exclusive license agreement with Seattle Genetics, Inc. (now acquired by Pfizer Inc.) in 2021. The company has granted the global development and commercialization rights of vedolizumab (code: RC48) in the Rongchang Bio region (i.e. all Asian regions except Japan and Singapore) outside of its territory. Currently, Pfizer is progressing overseas clinical trials of RC48 according to plan. The main challenges faced in the internationalization process include differences in regulatory environments in different countries and regions, the complexity of market access policies, and the dynamic changes in the competitive environment. The company is actively collaborating closely with Pfizer to provide necessary support and data to facilitate clinical development and application in overseas markets.
3 m ago
STMicroelectronics invests $60 million to upgrade its French factory and build a pilot line for advanced chips.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.